You are here

  • Home
  • Archive
  • Volume 8, Issue Suppl 3
  • 246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups

Article Text

Article menu

Download PDFPDF

Regular and young investigator award abstracts
Checkpoint blockade therapy
246 Clinicopathologic and genomic correlates of tumor mutational burden and its impact on PD-(L)1 inhibition efficacy in non-small cell lung cancer according to different PD-L1 expression subgroups

https://doi.org/10.1136/jitc-2020-SITC2020.0246

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.